Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Systemic effects of local radiotherapy
2009
The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
2010
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
The RNA Binding Protein Quaking Regulates Formation of circRNAs
2015 Standout
The development of proteasome inhibitors as anticancer drugs
2004
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
S-1 in the treatment of pancreatic cancer
2014
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
2005 StandoutNobel
MYC on the Path to Cancer
2012 Standout
MEK in cancer and cancer therapy
2013
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Management of borderline and locally advanced pancreatic cancer: Where do we stand?
2014
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
2003 StandoutNobel
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
To differentiate or not — routes towards metastasis
2012
Transforming growth factor-β-induced epithelial–mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression
2010
Cancer drug resistance: an evolving paradigm
2013 Standout
Head and neck cancer
2008 Standout
Induction chemotherapy and radiotherapy in locally advanced non–small cell lung cancer
2004
The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers
2016
Pancreatic cancer
2016 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Regulation of apoptosis by the ubiquitin and proteasome pathway
2002
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Ubiquitin Ligase Activity of TFIIH and the Transcriptional Response to DNA Damage
2005 StandoutNobel
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Proteasome inhibition in cancer: Development of PS-341
2001
Immunity, Inflammation, and Cancer
2010 Standout
The proteasome: structure, function, and role in the cell
2003
Therapies Directed Against Epidermal Growth Factor Receptor in Aerodigestive Carcinomas
2007
Apoptosis
2002 Standout
Clinical update: proteasome inhibitors in hematologic malignancies
2003
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Clinical update: proteasome inhibitors in solid tumors
2003
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
EMT: 2016
2016 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
The Proteasome
2001
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
The proteasome: a suitable antineoplastic target
2004
Therapeutic Targeting of Myc
2010
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma
2012
Cancer stem cells: mirage or reality?
2009
Idiopathic pulmonary fibrosis
2011 Standout
Hypoxic tumor cell radiosensitization through nitric oxide
2008
Metastatic colonization by circulating tumour cells
2016 StandoutNature
The role of the ubiquitin/proteasome system in cellular responses to radiation
2003
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
2010
Development of the Proteasome Inhibitor PS-341
2002
Early events in cell adhesion and polarity during epithelial-mesenchymal transition
2012
Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control
2008
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Head and Neck Cancer
2020 Standout
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
2004 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Spermidine in health and disease
2018 StandoutScience
Proteasome Inhibition As a Novel Therapeutic Target in Human Cancer
2005
Spermidine Prolongs Lifespan and Prevents Liver Fibrosis and Hepatocellular Carcinoma by Activating MAP1S-Mediated Autophagy
2017
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer
2010
Multiple Myeloma
2011 Standout
Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review
2008
IκB-kinaseβ-dependent NF-κB activation provides radioprotection to the intestinal epithelium
2004
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of Suzanne Russo being referenced
Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma
2006
Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma
2001
Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions
2008
Phase II Study of Capecitabine With Concomitant Radiotherapy for Patients With Locally Advanced Pancreatic Cancer: Up-Regulation of Thymidine Phosphorylase
2007
Locally Advanced Pancreatic Cancer: A Review
2007
Emerging Raf inhibitors
2009
Emerging MEK inhibitors
2010
Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study
2005
Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB
2001
Phase I Study of Capecitabine With Concomitant Radiotherapy for Patients With Locally Advanced Pancreatic Cancer: Expression Analysis of Genes Related to Outcome
2005
A Novel Sulindac Derivative Inhibits Lung Adenocarcinoma Cell Growth through Suppression of Akt/mTOR Signaling and Induction of Autophagy
2013
Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead-Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal Effects
2005
Abstract 1632: Co-targeting mTOR and IGF-1R/IR results in synergistic activity against a broad array of tumor cell lines, independent of KRAS mutation status
2010
Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose‐escalating conformal thoracic radiation therapy in unresectable Stage IIIA/B nonsmall cell lung carcinoma
2000